{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:07:11Z","timestamp":1787587631701,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.urolonc.2026.111037","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:50:39Z","timestamp":1772412639000},"page":"111037","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Real-world functional and oncologic outcomes of prostate gland ablation vs. standard of care therapies for localized prostate: A retrospective cohort study using the TriNetX database"],"prefix":"10.1016","volume":"44","author":[{"given":"Eusebio Luna","family":"Velasquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renil S.","family":"Titus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vatsala","family":"Mundra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Riveros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Miles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharam","family":"Kaushik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre Luis","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.D.","family":"Wallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Satkunasivam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.urolonc.2026.111037_bib0001","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/MOU.0000000000000171","article-title":"Focal therapy of prostate cancer: making steady progress toward a first-line image-guided treatment modality","volume":"25","author":"Polascik","year":"2015","journal-title":"Curr Opin Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2026.111037_bib0002","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s00345-023-04354-7","article-title":"Contemporary patterns of local ablative therapies for prostate cancer at United States cancer centers: results from a national registry","volume":"41","author":"Koelker","year":"2023","journal-title":"World J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2026.111037_bib0003","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.eururo.2018.06.006","article-title":"A multicentre study of 5-year outcomes following focal therapy in treating clinically significant nonmetastatic prostate cancer","volume":"74","author":"Guillaumier","year":"2018","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2026.111037_bib0004","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1097\/JU.0000000000000456","article-title":"Hemigland cryoablation of localized low, intermediate, and high-risk prostate cancer: oncologic and functional outcomes at 5 years","volume":"202","author":"Oishi","year":"2019","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.111037_bib0005","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.eururo.2018.12.030","article-title":"Early-medium-term outcomes of primary focal cryotherapy to treat nonmetastatic clinically significant prostate cancer from a prospective multicenter registry","volume":"76","author":"Shah","year":"2019","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2026.111037_bib0006","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/bju.14710","article-title":"Medium-term oncological outcomes in a large cohort of men treated with either focal or hemi-ablation using high-intensity focused ultrasonography for primary localized prostate cancer","volume":"124","author":"Stabile","year":"2019","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.urolonc.2026.111037_bib0007","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/s41391-021-00369-6","article-title":"Conventional radical versus focal treatment for localized prostate cancer: a propensity score weighted comparison of 6-year tumor control","volume":"24","author":"Van Son","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"10.1016\/j.urolonc.2026.111037_bib0008","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.euf.2024.04.008","article-title":"Comparative effectiveness of partial gland cryoablation versus robotic radical prostatectomy for cancer control","volume":"10","author":"Zhu","year":"2024","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urolonc.2026.111037_bib0009","series-title":"TriNetX global health research network","year":"2024"},{"key":"10.1016\/j.urolonc.2026.111037_bib0010","series-title":"NCCN clinical practice guidelines in oncology: prostate cancer. Version 2.2024","year":"2024"},{"key":"10.1016\/j.urolonc.2026.111037_bib0011","series-title":"R: a language and environment for statistical computing","year":"2024"},{"key":"10.1016\/j.urolonc.2026.111037_bib0012","series-title":"XLSTAT statistical and data analysis solution, version 2024.3","year":"2024"},{"issue":"4","key":"10.1016\/j.urolonc.2026.111037_bib0013","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/JU.0000000000000298","article-title":"Extensive histological sampling following focal therapy of clinically significant prostate cancer with high-intensity focused ultrasound","volume":"202","author":"Mortezavi","year":"2019","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2026.111037_bib0014","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/bju.15268","article-title":"Magnetic resonance imaging-guided transurethral ultrasound ablation in patients with localized prostate cancer: 3-year outcomes of a prospective phase I study","volume":"127","author":"Nair","year":"2021","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.urolonc.2026.111037_bib0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.eururo.2016.08.044","article-title":"New and established technology in focal ablation of the prostate: a systematic review","volume":"71","author":"Valerio","year":"2017","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.111037_bib0016","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1148\/radiol.2019181987","article-title":"Image-guided irreversible electroporation of localized prostate cancer: functional and oncologic outcomes","volume":"292","author":"Collettini","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.urolonc.2026.111037_bib0017","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.humpath.2021.11.005","article-title":"High-intensity focused ultrasound for the treatment of prostate cancer: assessing location of failure after focal therapy in prostate cancer and review of histological characteristics and clinicopathologic correlates after treatment-a 5-year experience","volume":"119","author":"Collins","year":"2022","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.urolonc.2026.111037_bib0018","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/his.15507","article-title":"Treatment-related changes in the prostate: past, present and future therapies","volume":"88","author":"Collins","year":"2026","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.urolonc.2026.111037_bib0019","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s00261-018-1715-9","article-title":"Temporal changes in MRI appearance of the prostate after focal ablation","volume":"44","author":"H\u00f6tker","year":"2019","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.urolonc.2026.111037_bib0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.urology.2023.09.004","article-title":"Biopsy and erectile functional outcomes of partial prostate ablation: a systematic review and meta-analysis of prospective studies","volume":"182","author":"Busby","year":"2023","journal-title":"Urology"},{"issue":"11","key":"10.1016\/j.urolonc.2026.111037_bib0021","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1001\/jama.2017.1704","article-title":"Association between radiation therapy, surgery, or observation for localized prostate cancer and patient-reported outcomes after 3 years","volume":"317","author":"Barocas","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.urolonc.2026.111037_bib0022","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.adro.2016.05.003","article-title":"Radiation-induced erectile dysfunction: recent advances and future directions","volume":"1","author":"Mahmood","year":"2016","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.urolonc.2026.111037_bib0023","series-title":"Clinically localized prostate cancer: AUA\/ASTRO\/SUO guideline","author":"Sanda","year":"2022"},{"key":"10.1016\/j.urolonc.2026.111037_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2021.696242","article-title":"Focal therapy for prostate cancer: complications and their treatment","volume":"8","author":"Rakauskas","year":"2021","journal-title":"Front Surg"},{"issue":"7","key":"10.1016\/j.urolonc.2026.111037_bib0025","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1089\/end.2018.0809","article-title":"Comprehensive evaluation of focal therapy complications in prostate cancer: a standardized methodology","volume":"33","author":"Bakavicius","year":"2019","journal-title":"J Endourol"},{"issue":"4","key":"10.1016\/j.urolonc.2026.111037_bib0026","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s41391-021-00390-9","article-title":"Oncological and functional outcome after partial prostate HIFU ablation with Focal-One\u00ae: a prospective single-center study","volume":"24","author":"Dellabella","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"6","key":"10.1016\/j.urolonc.2026.111037_bib0027","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S1470-2045(12)70121-3","article-title":"Focal therapy for localized unifocal and multifocal prostate cancer: a prospective development study","volume":"13","author":"Ahmed","year":"2012","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.urolonc.2026.111037_bib0028","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41391-023-00698-8","article-title":"Functional outcomes and safety of focal therapy for prostate cancer: a systematic review on results and patient-reported outcome measures (PROMs)","volume":"27","author":"Nicoletti","year":"2024","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"10.1016\/j.urolonc.2026.111037_bib0029","doi-asserted-by":"crossref","first-page":"193.e1","DOI":"10.1016\/j.urolonc.2022.02.007","article-title":"Outcomes of partial gland ablation using high intensity focused ultrasound for prostate cancer","volume":"40","author":"Hong","year":"2022","journal-title":"Urol Oncol"},{"issue":"12","key":"10.1016\/j.urolonc.2026.111037_bib0030","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.3390\/cancers16122178","article-title":"A description and safety overview of irreversible electroporation for prostate tissue ablation in intermediate-risk prostate cancer patients: preliminary results from the PRESERVE trial","volume":"16","author":"George","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"17","key":"10.1016\/j.urolonc.2026.111037_bib0031","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.3390\/cancers17172863","article-title":"Oncological efficacy and safety of minimally invasive focal and whole-gland interventions in the treatment of low- and intermediate-risk prostate cancer: a systematic review and meta-analysis","volume":"17","author":"Skribek","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.urolonc.2026.111037_bib0032","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11701-024-02123-1","article-title":"Comparative study of HIFU partial gland ablation and robot-assisted radical prostatectomy for localized prostate cancer: an evidence-based approach","volume":"18","author":"Wang","year":"2024","journal-title":"J Robot Surg"},{"issue":"24","key":"10.1016\/j.urolonc.2026.111037_bib0033","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.3390\/cancers15245740","article-title":"Validation of claims data for absorbing pads as a measure for urinary incontinence after radical prostatectomy, a national cross-sectional analysis","volume":"15","author":"Baas","year":"2023","journal-title":"Cancers (Basel)"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926000487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926000487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T05:16:46Z","timestamp":1776575806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143926000487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1078143926000487"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.111037","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world functional and oncologic outcomes of prostate gland ablation vs. standard of care therapies for localized prostate: A retrospective cohort study using the TriNetX database","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.111037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111037"}}